Objective: To estimate the prevalence of milk hypersensitivity in Finnish adults. Design: Cross-sectional study. Subjects: Two hundred men and 206 women aged 27 y randomly recruited from the population register in southwestern Finland. Interventions: The subjects were interviewed about their dairy product consumption, abdominal discomfort after dairy product intake and lactose intolerance. From serum samples, serum reactivity to milk protein and milk-speci®c IgG 1 , IgG 2 , IgG 3 and IgA were measured. Results: About 20% of the subjects reported abdominal discomfort after dairy product intake, whereas only 6.4% had been diagnosed to have lactose intolerance. The amount of milk consumed correlated well with the serum assay results in subjects reporting abdominal discomfort but not in subjects who were free from these symptoms. Among subjects with no record of dairy product restriction or lactose intolerance, those experiencing abdominal discomfort after dairy product intake had signi®cantly higher serum reactivity to milk protein than those without such discomfort. The concentrations of serum milk-speci®c antibodies did not differ between these two groups. The prevalence of milk hypersensitivity in this population was estimated to be 3 ± 6%. Conclusions: Milk hypersensitivity may be as common in adults as in infants. The measurement of serum reactivity to milk protein may prove useful in screening milk hypersensitivity in subjects who have not restricted their dairy product consumption.
Introduction
Adverse reactions to food may be classi®ed as non-immune mediated food intolerance or immune mediated food hypersensitivity (Bruijnzeel-Koomen et al, 1995) . Adverse reactions to milk include lactose intolerance caused by lactase (b-galactosidase) de®ciency and milk hypersensitivity. About 17% of Finns have lactase de®ciency (Sahi, 1974) . About 70% of these respond to two glasses of milk (Sahi et al, 1983; Savaiano & Levitt, 1987; Vesa et al, 1997) corresponding roughly to the average daily milk consumption in Finland (Anonymous, 1998) . Therefore, about 12% of Finns can be considered lactose-intolerant. Milk hypersensitivity is mediated by immunological mechanisms. About 3% of infants suffer from cow milk allergy (Hùst & Halken, 1990; Savilahti et al, 1991; Schrander et al, 1993) . Most of them have been reported to become symptom-free by the age of three (Hùst & Halken, 1990) , and milk hypersensitivity is therefore considered rare among adults. Nevertheless, our recent study suggests that this may not be the case (Pelto et al, 1998) .
Undegraded dietary antigens can penetrate the intestinal epithelial surface in immunologically signi®cant quantities in healthy and hypersensitive subjects (Lovegrove et al, 1993) . Transferred antigens stimulate the production of speci®c antibodies which is, however, strictly controlled in healthy subjects (Challacombe & Tomasi, 1980) . Appearance of IgE is known to correlate with hypersensitivity reactions but the clinical relevance of IgG, IgA and IgM isotypes produced in response to dietary antigens is obscure (Bruijnzeel-Koomen et al, 1995) . Most recently published papers suggest that IgG and IgA may have a role in hypersensitivity reactions (Keller et al, 1996; Marinkovich, 1996; Wutrich, 1996; Awazuhara et al, 1997; Duchen et al, 1997; Kolopp-Sarda et al, 1997; Shimojo et al, 1997; Spuergin et al, 1997) . In our previous study, IgE was not a major antibody in milk-hypersensitive adults (Pelto et al, 1998) . Similar results have been obtained by other groups (Bengtsson et al, 1996; Werfel et al, 1997; Bischoff et al, 1997) . We measured serum reactivity to milk protein and milk-speci®c IgG 1 , IgG 2 , IgG 3 and IgA antibodies in serum and estimated the prevalence of milk hypersensitivity in young adults.
Methods

Study population
The subjects were randomly drawn from the population registers of the city of Turku and adjacent rural and urban communities in southwestern Finland. The study population was made up of 200 men and 206 women aged 27 y. Before implementation, the study was approved by the Ethical Committee of the Research Centre of the Social Insurance Institution.
Interview
The participants were asked whether they had ever been diagnosed by a physician to have lactose intolerance, whether they had experienced abdominal discomfort after the intake of dairy products, and whether they had restricted their consumption of such products (milk, sour milk, yoghurt or ice cream) because of the symptoms.
The participants were also asked about their daily consumption of dairy products. The amount of milk, sour milk and yoghurt was recorded as glasses (equalling to 2 dl). Hard and soft cheeses were recorded as slices (equalling to 15 g) and tablespoons (equalling to 20 g), respectively. Consumption of ice cream was recorded as portions (equalling to 1 dl). The records were checked by a dietician. For the results, the amounts were calculated in dl or g.
Serum assays
Samples. Blood samples were collected in the morning, after an overnight fast. After separation, serum available from 402 study subjects was stored at À70 C. Serum of a healthy (no lactose intolerance, no milk hypersensitivity) 26 y old woman not belonging to the study group served as a negative control. Milk-speci®c antibodies were measured from randomly selected 71 subjects with no abdominal discomfort after dairy product intake and from all reporting abdominal discomfort (n 82).
Reagents. Hank's balanced salt solution (HBSS) was made without phenol red, pH 7.4 and supplemented with 0.1% gelatin (gHBSS). Monoclonal Mouse Anti-Human IgG 1 , IgG 2 , IgG 3 and IgA and the labelled Fab (AP-F(ab H )2 Rabbit Anti-Mouse IgG (HL)) were purchased from Zymed (San Francisco, CA, USA). The substrate (AMPPD) were from Tropix (Bedford, MA, USA). Dilutions were made in gHBSS unless otherwise stated.
Measurement of serum reactivity to milk protein. The capacity of antigen-antibody complexes to activate phagocytes were measured as previously described (Pelto et al, 1998) .
Measurement of milk-specific antibodies. Milk-specific IgG 1 , IgG 2 , IgG 3 and IgA were measured with ELISA modified for luminometry. 100 ml of 1 : 10 diluted serum was added to milk protein coated tubes and incubated for 30 min at 37 C. Serum was removed by a vacuum and the tube was washed with 500 ml of gHBSS. 100 ml 1 : 100 diluted anti-human immunoglobulin isotype antibody (IgA, IgG 1 , IgG 2 or IgG 3 ) was added and incubated for 30 min at 4 C. After vacuum clearance and a wash 100 ml 1 : 200 diluted anti-mouse immunoglobulin Fab-fragment labelled with alkaline phophatase was added and incubated for 30 min at 4 C. After vacuum clearance, the tube was washed three times so that the unspecific label would not interfere. AMPPD was diluted 1 : 250 in 0.1 M carbonate buffer and 100 ml of substrate was added just before the measurement. The reaction was measured with a luminometer for 30 min at 37 C and the peak chemiluminescence was recorded.
Statistics
The levels of serum reactivity to milk protein and the concentrations of milk-speci®c antibodies in serum were adjusted to the negative control, and were expressed as percentage of the negative control.
The study population was divided into six groups according to reported abdominal symptoms, restriction of dairy product consumption and lactose intolerance. The analysis of variance (ANOVA) was used to compare the differences between groups, and Fisher's LSD test was used in pairwise comparisons. Due to skewed distributions, the variables were logarithmically transformed before analysis. The associations between serum reactivity to milk protein and milk-speci®c antibodies were analysed by Pearson's correlation analysis, and stepwise regression analysis was performed to ®nd out which of the milkspeci®c antibodies best indicated the level of serum reactivity to milk protein.
Differences in dairy product consumption between the de®ned study groups were analysed using Mann ± Whitney U-test.
Results
Interview
The results of the interview (Table 1) showed no major differences between men and women and their results were therefore combined for further analysis.
The study population was divided into six groups according to the symptoms, dairy product consumption and reported lactose intolerance (Figure 1 ). The groups with one and two subjects were not analysed statistically. The remaining four groups were de®ned as group A (no symptoms, no restriction of dairy product consumption, no lactose intolerance), group B (symptoms, no dairy product restriction, no lactose intolerance), group C (symptoms, dairy product restriction, no lactose intolerance) and group D (symptoms, dairy product restriction and diagnosed lactose intolerance).
Dairy product consumptions in groups A, B, C and D are presented in Table 2 . As expected, consumption of liquid milk products (milk, sour milk and yoghurt) was signi®cantly lower in subjects with restricted dairy product consumption due to discomfort (groups C and D) than in those without any abdominal discomfort and with unrestricted dairy product consumption (group A). Subjects with lactose intolerance restricting dairy product consumption (group D) had signi®cantly lower dairy product consumption than subjects with abdominal discomfort after dairy product consumption but without diagnosed lactose intolerance (groups B and C). The consumption of cheeses and ice cream did not differ between the groups.
Serum assays
Distributions of serum reactivity to milk protein and milkspeci®c antibodies are presented in Figure 2 .
Serum assays vs interview results
The results of serum reactivity to milk proteins and milkspeci®c antibodies in the four groups (A, B, C, D) are presented in Table 3 . In groups with abdominal discomfort after dairy product consumption the subjects with restricted dairy product consumption (groups C and D) had signi®cantly lower serum reactivity to milk protein and lower concentrations of milk-speci®c antibodies than those with unrestricted dairy product consumption (group B). In subjects with abdominal discomfort after dairy product consumption (groups B, C and D), serum reactivity to milk protein and concentrations of IgG 2 and IgG 3 were signi®cantly lower in subjects consuming less than 2 dl milk per day than in those consuming 2 dl or more milk per day. Geometric mean percentage of serum reactivity to milk protein was 109 in subjects consuming less than 2 dl milk per day and 283 in subjects consuming 2 dl or more milk per day, P`0.0001. For milk-speci®c IgG 2 and IgG 3 geometric means were 60 and 103, P`0.0001; and 51 and 75, P`0.007, respectively. There was no such correlation in subjects without abdominal discomfort (group A). 
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Of the subjects without milk restriction and lactose intolerance, those with abdominal discomfort after dairy product consumption (group B) had signi®cantly higher serum reactivity to milk protein than those without abdominal discomfort (group A) (p`0.01). Concentrations of milk-speci®c antibodies did not differ between these groups.
Correlation of serum reactivity to milk protein and milkspeci®c antibodies All milk-speci®c antibodies correlated positively with serum reactivity to milk protein in subjects with abdominal discomfort after milk intake (groups B, C and D) ( Table 4) . Similar correlations excepting milk-speci®c IgG 2 were seen in subjects without abdominal discomfort (Group A). In a stepwise regression analysis covering all study groups, all antibodies proved signi®cant predictors of serum reactivity (R 2 0.74).
Discussion
The aim of this study was to estimate the prevalence of milk hypersensitivity in a group of young adults. According to the interview, 6.4% of the subjects had had lactose intolerance diagnosed by a physician. This is less than expected since about 12% of Finns are reported to have lactose intolerance with symptoms (Sahi, 1974; Sahi et al, 1983; Savaiano & Levitt, 1987; Vesa et al, 1997) . Lactose intolerance is well known and often self-diagnosed and therefore subjects do not necessarily consult a physician for it. On the other hand, the proportions of subjects reporting abdominal discomfort and restricting dairy product consumption were higher than expected, namely 20.2% and 16.5%, respectively. Lactose intolerance alone can not explain this. It seems obvious that in addition to lactose intolerance, milk hypersensitivity can produce symptoms to some adults (Pelto et al, 1998) whereas others probably misconnect their symptoms to milk intake. Serum assay results correlated well with milk product consumption in subjects with abdominal discomfort after milk product intake but not in those free from such symptoms. In children with coeliac disease, gluten challenge is known to signi®cantly increase IgG and IgA levels to gluten, whereas gluten elimination decreases these (Scott et al, 1985; Lindberg et al, 1985; Wauters et al, 1991) . In healthy subjects a chronic increase of dietary antigens does not affect food antibody concentrations even if single large loads of dietary antigens may lead to formation of food antibodies as a physiological response (Gallagher et al, 1983) . Therefore, in long term consumption, the amount of dietary antigens may not in¯uence the concentration of antibodies in healthy subjects, whereas this may happen in subjects with gastrointestinal problems. This may result from increased penetration of antigens through the pathologically altered intestinal mucosa.
Subjects with lactose intolerance diagnosed by a physician (group D) consumed signi®cantly less milk than those in groups B and C who also had reported discomfort after milk consumption but in whom this diagnosis had not been veri®ed. Therefore, a proper diagnosis by a physician seems to in¯uence the subject's dietary habits. The differences in serum assay results between groups A and D were probably unrelated to lactose intolerance. Immunological serum assays are unlikely to be affected by non-immune mediated intolerance but rather by differences in dairy product consumption.
Serum reactivity to milk protein was signi®cantly higher in subjects with abdominal discomfort after dairy product intake but with no milk restriction and no lactose intolerance (group B) than in those without any symptoms during unrestricted dairy product consumption (group A). A similar difference was seen in our previous study between milkhypersensitive and control subjects (Pelto et al, 1998) . Therefore, it seems that group B included signi®cantly more milk-hypersensitive subjects than group A. On the other hand, milk restriction reduces serum reactivity to milk protein. Therefore, group C which was comparable to group B, except for restricted dairy product consumption, showed low reactivity similar to that in group A even if there may have been equal proportions of milk-hypersensitive subjects in groups B and C.
Milk-speci®c antibodies correlated well with serum reactivity in subjects with abdominal discomfort after milk intake (groups B, C and D) and in healthy subjects (group A) except for milk-speci®c IgG 2 . The best correlation was obtained when all measured antibodies were taken into account. In addition to the antibodies, also complement compounds participate to the reaction of serum reactivity to milk protein. The concentrations of milk-speci®c antibodies did not differ between groups A and B. Nevertheless, serum reactivity to milk protein was signi®cantly higher in group B than in group A. This difference in serum reactivity to milk protein between groups A and B is probably related to different correlations of IgG 2 with serum reactivity, as seen in Table 4 . In groups C and D serum reactivity and the concentrations of milk-speci®c antibodies were lower than in groups A and B because of smaller consumption of milk products. We did not measure serum IgG 4 and IgM in this study because our pilot study showed limited range of the values and little variations between the study subjects in these antibodies.
Conclusions
The subjects participating in this study were not originally recruited for screening milk hypersensitivity but for general health monitoring purposes. Lactose tolerance tests or milk challenges were therefore not performed. Groups B and C presumably included both lactose-intolerant and milkhypersensitive subjects as well as subjects misconnecting their symptoms to milk intake. Taking these aspects into account, we can estimate the prevalence of milk hypersensitivity in young Finnish adults. According to epidemiological studies, about 12% of Finns have lactase de®ciency with symptoms (Sahi, 1974; Sahi et al, 1983; Savaiano & Milk hypersenstivity in young adults L Pelto et al Levitt, 1987; Vesa et al, 1997) . Out of our 406 study subjects this would be 49 subjects (vs the actual number of 25 subjects who had been diagnosed by a physician, Figure 1 ). Subtracting 49 subjects from the total of 82 subjects with abdominal discomfort after dairy product intake, we have 33 subjects who can be considered milkhypersensitive subjects. Assuming that 60% of them can be expected to misrelate their symptoms to milk intake (Bengtsson et al, 1996; Bock, 1987; Nùrgaard & Bindslev-Jensen, 1992) , there may be 13 subjects with more probable milk hypersensitivity. Using the actual ®gures (Figure 1 ), we had 57 potential milk-hypersensitive subjects (groups B and C) of whom 23 (40%) may have milk hypersensitivity. The prevalence of milk hypersensitivity can then be estimated to be between 13 ± 23 out of 406, or 3 ± 6%. This compares well with the prevalence of cow milk allergy in children under the age of three which is reported to vary between 2.2 ± 3.5% (Hùst & Halken, 1990; Savilahti et al, 1991; Schrander et al, 1993) . On the other hand, also other groups than B and C may include milkhypersensitive subjects who have not connected their symptoms to milk or are both lactose-intolerant and milkhypersensitive. Our estimate is based on a sample of 27 y old adults. It remains to be studied what the prevalences of milk hypersensitivity are in age groups younger and older than 27 y. Serum reactivity to milk protein may be a good method for screening milk hypersensitivity in subjects who have not previously connected their symptoms to milk, and have not restricted their dairy product consumption. This kind of test is at present available only for screening IgE-mediated milk hypersensitivity. The same principle may also be applied to screen for hypersensitivity to other food stuffs.
